Boston, MA, United States of America

Alexandra Lantermann

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alexandra Lantermann: Innovator in Cancer Treatment

Introduction

Alexandra Lantermann is a prominent inventor based in Boston, MA (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of new therapeutic methods.

Latest Patents

Lantermann holds 1 patent for her invention titled "Methods and compositions for treating cancer using P2RX2 inhibitors." This groundbreaking invention provides methods for treating cancer using P2RX2 inhibitors, including P2RX2 inhibitory antibodies. The patent also features compositions containing P2RX2 inhibitors, methods for diagnosing patients with P2RX2-associated cancer, and methods for predicting the response of cancer in a subject to treatment with P2RX2 inhibitors.

Career Highlights

Lantermann is currently associated with Flagship Pioneering Innovations V, Inc., where she continues to advance her research in cancer therapies. Her work is characterized by a commitment to improving patient outcomes through innovative treatment options.

Collaborations

Throughout her career, Lantermann has collaborated with notable colleagues, including Avak Kahvejian and Jordi Mata-Fink. These partnerships have further enhanced her research and development efforts in the field of cancer treatment.

Conclusion

Alexandra Lantermann is a dedicated inventor whose work in cancer treatment is paving the way for new therapeutic approaches. Her innovative methods and compositions are set to make a significant impact in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…